Coronavirus Disease (COVID-19) and Peritoneal Malignancies

Solanki SL, Thota RS, Garg R, Pingle AA, Goswami J, Ranganath N et al (2020) Society of Onco-Anesthesia and Perioperative Care (SOAPC) advisory regarding perioperative management of onco-surgeries during COVID-19 pandemic. Indian J Anaesth 64:S97–S102 Sharma DC (2020) Lockdown poses new challenges for cancer care in India. Lancet Oncol 21:884 Glehen O, Kepenekian V, Bouché O, Gladieff L, Honore C, RENAPE-BIG-RENAPE (2020) Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. J Visc Surg 157(3S1):S25–S31 LYW L, Cazier JB, Starkey T, Turnbull CD, UK Coronavirus Cancer Monitoring Project Team, Kerr R, Middleton G (2020) COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 395(10241):1919–1926 COVIDSurg Collaborative (2020) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study [published online ahead of print, 2020 May 29] [published correction appears in Lancet. 2020 Jun 9]. Lancet S0140–6736(20):31182-X Solanki SL, Mukherjee S, Agarwal V, Thota RS, Balakrishnan K, Shah SB, Desai N, Garg R, Ambulkar RP, Bhorkar NM, Patro V, Sinukumar S, Venketeswaran MV, Joshi MP, Chikkalingegowda RH, Gottumukkala V, Owusu-Agyemang P, Saklani AP, Mehta SS, Seshadri RA, Bell JC, Bhatnagar S, Divatia JV (2019) Society of Onco- Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth 63:972–987 Solanki SL, Kumar PP, DeSouza A, Saklani AP (2018) Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: report of two cases. Indian J Anaesth 62:225–228 Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G et al (2020) Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol 27:1717–1720 Shrikhande SV, Pai PS, Bhandare MS, Bakshi G, Chaukar DA, Chaturvedi P, Goel M, Gulia A, Qureshi SS, Maheshwari A, Moiyadi A, Nair S, Nair NS, Karimundackal G, Saklani AP, Shankhadhar VK, Parmar V, Divatia JV, CS P, Puri A, Badwe RA (2020) Outcomes of elective major cancer surgery during COVID-19 at Tata Memorial Centre. Ann Surg 272:e249–e252 Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, Bricou A, Canlorbe G, Carcopino X, Chauvet P, Collinet P, Coutant C, Dabi Y, Dion L, Gauthier T, Graesslin O, Huchon C, Koskas M, Kridelka F, Lavoue V, Lecointre L, Mezzadri M, Mimoun C, Ouldamer L, Raimond E, Touboul C (2020) Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod 49:101729 Uwins C, Bhandoria GP, Shylasree TS, Butler-Manuel S, Ellis P, Chatterjee J, Tailor A, Stewart A, Michael A (2020) COVID-19 and gynecological cancer: a review of the published guidelines. Int J Gynecol Cancer 30:1424–1433